cepharanthine has been researched along with Inflammation in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (50.00) | 24.3611 |
| 2020's | 4 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Edwards, BS; Graves, SW; Saunders, MJ; Sklar, LA; Zhu, J | 1 |
| Chen, G; Dou, G; Gan, H; Gu, R; Han, P; Li, J; Liang, D; Liu, H; Liu, M; Liu, S; Liu, T; Meng, Z; Wu, Z; Zhou, H; Zhu, X | 1 |
| Cheng, RJ; Fox, DA; Hu, Y; Li, S; Liu, Y; Lu, C; Luo, Y; Pu, Y; Tang, Z; Tsou, PS; Wei, S; Wen, J; Wu, L; Zhang, Q; Zhong, Y | 1 |
| Cao, Y; Wang, M; Wang, S; Wu, Y; Xu, X | 1 |
| Han, F; Liang, Q; Liang, S; Piao, X; Shao, S; Wu, Y; Zhao, D; Zhao, J | 1 |
| Koman, I; Okediji, P; Rogosnitzky, M | 1 |
| Chen, X; Hu, G; Huang, H; Qian, A; Wang, C; Xu, H | 1 |
| Hagiwara, S; Hasegawa, A; Koga, H; Kudo, K; Kusaka, J; Noguchi, T | 1 |
1 review(s) available for cepharanthine and Inflammation
| Article | Year |
|---|---|
Cepharanthine: a review of the antiviral potential of a Japanese-approved alopecia drug in COVID-19.
Topics: Animals; Anti-Inflammatory Agents; Antiviral Agents; Benzylisoquinolines; COVID-19; COVID-19 Drug Treatment; Drug Repositioning; Humans; Inflammation; Japan; SARS-CoV-2; Virus Replication | 2020 |
7 other study(ies) available for cepharanthine and Inflammation
| Article | Year |
|---|---|
Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
Topics: Animals; Biotinylation; Flow Cytometry; Fluorescence Resonance Energy Transfer; Green Fluorescent Proteins; High-Throughput Screening Assays; Humans; Inflammation; Kinetics; Microspheres; Peptide Hydrolases; Peptides; Reproducibility of Results; Temperature | 2010 |
Cepharanthine Ameliorates Pulmonary Fibrosis by Inhibiting the NF-κB/NLRP3 Pathway, Fibroblast-to-Myofibroblast Transition and Inflammation.
Topics: Animals; Bleomycin; Collagen; COVID-19; Fibroblasts; Inflammation; Lung; Myofibroblasts; NF-kappa B; NLR Family, Pyrin Domain-Containing 3 Protein; Pulmonary Fibrosis; Rats; Transforming Growth Factor beta1 | 2023 |
Herbal compound cepharanthine attenuates inflammatory arthritis by blocking macrophage M1 polarization.
Topics: Animals; Arthritis, Experimental; Arthritis, Rheumatoid; Benzylisoquinolines; Inflammation; Lipopolysaccharides; Mice | 2023 |
Cepharanthine promotes the effect of dexmedetomidine on the deposition of β-amyloid in the old age of the senile dementia rat model by regulating inflammasome expression.
Topics: Aging; Animals; Benzylisoquinolines; Brain; Dexmedetomidine; Inflammasomes; Inflammation; Male; Mitochondria; Oxidative Stress; Rats, Sprague-Dawley; Reactive Oxygen Species | 2019 |
Cepharanthine attenuates cerebral ischemia/reperfusion injury by reducing NLRP3 inflammasome-induced inflammation and oxidative stress via inhibiting 12/15-LOX signaling.
Topics: Animals; Benzylisoquinolines; Brain; Dose-Response Relationship, Drug; Homeodomain Proteins; Infarction, Middle Cerebral Artery; Inflammasomes; Inflammation; Interleukin-18; Interleukin-1beta; Male; Mice; Microglia; Nerve Tissue Proteins; NLR Family, Pyrin Domain-Containing 3 Protein; Oxidative Stress; Reperfusion Injury | 2020 |
Cepharanthine, an alkaloid from Stephania cepharantha Hayata, inhibits the inflammatory response in the RAW264.7 cell and mouse models.
Topics: Acute Lung Injury; Animals; Anti-Inflammatory Agents, Non-Steroidal; Benzylisoquinolines; Bronchoalveolar Lavage Fluid; Cell Line; Cell Survival; Dexamethasone; Disease Models, Animal; Extracellular Signal-Regulated MAP Kinases; I-kappa B Proteins; Inflammation; Interleukin-1beta; Interleukin-6; JNK Mitogen-Activated Protein Kinases; Lipopolysaccharides; Macrophages; Male; Mice; Mice, Inbred BALB C; NF-KappaB Inhibitor alpha; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Plant Preparations; Stephania; Transcription Factor RelA; Tumor Necrosis Factor-alpha | 2014 |
Cepharanthine exerts anti-inflammatory effects via NF-κB inhibition in a LPS-induced rat model of systemic inflammation.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Benzylisoquinolines; Cell Line; Disease Models, Animal; Inflammation; Interleukin-6; Lipopolysaccharides; Macrophages; Male; Mice; NF-kappa B; Nitrates; Nitrites; Rats; Rats, Wistar; Sepsis; Tumor Necrosis Factor-alpha | 2011 |